comprehensive -WSS

comprehensive

author：leisure time 2025-08-12 09:12:21 - browse：6268

Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT — Adobe

At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： WHO recommends second malaria vaccine

leisure time

WSS

With fresh data, a dynamic duo powers Eli Lilly to new heights

UPS workers' union leader explains what's at stake as strike edges closer

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Why Titanic fascinates society, still drawing tours to the wreckage

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

The United States is paying nearly triple for new Covid vaccines

leisure time

comprehensive

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

DIEP, the 'gold standard' of breast reconstruction, is under threat

RSV injection headlines need to be accurate for good uptake

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What we owe ALS patients — and why one company fell short

Malaria cases in Florida and Texas: Here’s what you need to know

The stability of $0 premiums in Medicare Advantage

Drug repurposing or repositioning? The language matters

Lawsuit highlights wrinkle for disputes over surprise medical bills

Wikipedia

Titanic submersible: What a 'catastrophic implosion' means and what officials found

US intelligence assessment says Iran not currently developing nuclear weapons

Study points to new risk in gene therapy death of Terry Horgan

How corporate America is slashing DEI workers amid backlash to diversity programs

IVG is promising — but it won’t replace IVF quite yet

CDC picks Alphabet's Verily for wasterwater surveillance contract

leisure time

explore

leisure time

focus